Salipro Biotech and Bicycle Therapeutics jointly announce results from their collaboration on a wild-type GPCR drug target. Results have just been published in Frontiers in Bioengineering and Biotechnology: “DirectMX – One-Step Reconstitution of Membrane Proteins From Crude Cell Membranes Into Salipro Nanoparticles”.
Link to article: https://www.frontiersin.org/articles/10.3389/fbioe.2020.00215/full
Salipro Biotech's Maria Lisa Knudsen pitches at SwedenBIO's Shark Tank, as part of their executive dinner event. Two sharks, Carolin Wiken at Paues Åberg Communications and Carl Kilander at HealthCap, decided to "invest" in us, meaning we will be receiving coaching from them.
Cambridge calling, Part 2! Salipro Biotech’s Robin Löving will be speaking at the 6th RSC / SCI Ion Channels as Therapeutic Targets symposium, Feb. 24-25. Robin will be sharing some of Salipro Biotech’s latest data generated with our pharma collaborators.
Cambridge calling, Part 1! Salipro Biotech’s Maria L. Knudsen is an invited speaker at Abzena’s 2nd Biopharmaceutical Discovery & Development Symposium on February 19th. Maria will be presenting data from our pharma collaborators on using the Salipro platform for antibody development. http://bit.ly/Abzenas2nd
Salipro will be live - Join us for a webinar: Our CSO Robin Löving has been invited to present how the Salipro platform can enable antibody discovery against challenging membrane proteins at the webinar “Discovery & Clinical Collaborations In Biotherapeutics”, organized by Oxford Global Conferences.
When: 29th January 2020, 4pm GMT (UK time)
To register/join: Click here.
Lisbon calling - wild-type GPCRs and more: Our CEO Jens Frauenfeld is invited speaker at #PEGS, presenting new data on the the direct membrane extraction (DirectMX) of membrane proteins.
We will join the BioEurope (link) from November 11-13 in Hamburg. Our CEO Jens Frauenfeld and André Heuer are looking forward to meet with our current pharma partners as well as new parties involved in membrane protein drug targets and antibody development. See you in Hamburg!
We are looking forward to exciting membrane protein cryoem and of course xray structures at the PSDI2019 in the coming days. Using the Salipro Biotech AB platform you can get more out of membrane proteins then just high resolution - visit our publication list for more details (link)
Our CSO Robin Löving will join the Festival of Biologics Conference in Basel, Switzerland, October 15-17. We present new data on challenging drug targets such as wild-type GPCRs using our unique Salipro direct membrane extraction platform (DirectMX). https://www.terrapinn.com/conference/festival-of-biologics/index.stm
Our CEO, Jens Frauenfeld is an invited speaker at the EMBO workshop “Tools for Structural Biology of Membrane Proteins” 7-9 Oct (Hamburg, Germany). We present new data on challenging drug targets, including the direct membrane extraction (DirectMX) of wild-type GPCRs: https://www.embl-hamburg.de/training/events/2019/TBP19-01/